{
  "ticker": "MAZE",
  "company_name": "MAZE",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06830629",
      "title": "A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Proteinuric Kidney Disease",
      "start_date": "2025-02-05",
      "completion_date": "2026-09",
      "enrollment": 0,
      "sponsor": "Maze Therapeutics"
    },
    {
      "nct_id": "NCT05249621",
      "title": "A Randomized Phase 1 of of MZE001 in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2022-02-07",
      "completion_date": "2022-12-21",
      "enrollment": 0,
      "sponsor": "Maze Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 2,
    "by_phase": {
      "PHASE2": 1,
      "PHASE1": 1
    },
    "by_status": {
      "RECRUITING": 1,
      "COMPLETED": 1
    },
    "active_trials": 1,
    "completed_trials": 1,
    "conditions": [
      "Healthy",
      "Proteinuric Kidney Disease"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:47:36.100839",
    "search_query": "MAZE",
    "url": "https://clinicaltrials.gov/search?term=MAZE"
  }
}